Business Context and Reporting Period
Company: Dr. Reddy's Laboratories Limited
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Quarter and nine months ended December 31, 2021
Filing Date: January 28, 2022
This filing serves as a disclosure of results of operations and financial condition. The company announced its financial results under International Financial Reporting Standards (IFRS) and Indian Accounting Standards (Ind AS) via a press release and attached exhibits.
Key Financial Metrics
The provided text is a cover sheet and does not contain specific numerical data for revenue, profit, cash flow, margins, debt, or liquidity.
Available Data: None. The filing references attached exhibits (99.1 through 99.4) which contain the actual financial tables, but the text of the Form 6-K itself does not list these values.
Material Changes
The filing text does not provide specific details regarding material changes versus prior comparable periods. It only confirms that results for the quarter and nine months ended December 31, 2021, have been announced.
Guidance, Outlook, and Risks
Guidance and Outlook: Not provided in the text of this filing.
Risks and Contingencies: Not provided in the text of this filing.
Unusual Items: Not mentioned in the text of this filing.
Management commentary and specific outlook details are contained within the attached press release (Exhibit 99.1) and financial results documents (Exhibits 99.2, 99.3, 99.4), which are not included in the input text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, profit, and margin figures for Q3 FY22.
- Examine Exhibit 99.2 for IFRS Unaudited Consolidated Financial Results to verify global performance metrics.
- Check Exhibit 99.3 for Ind AS Unaudited Consolidated Financial Results for local regulatory compliance data.
- Verify Exhibit 99.4 for Ind AS Unaudited Standalone Financial Results to assess the parent company's specific financial position.
- Confirm the Limited Review report status for the Ind AS results to understand the level of audit assurance provided.